Among the men, the participants with NAFLD were younger and had higher body weight, BMI, serum TG, and ALT than those without NAFLD, but there were no differences in height, serum TC, HDL-C, LDL-C, AST, GGT, ALB, Cr, FPG or UA between the two groups. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.